Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03853707
Title Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors City of Hope Medical Center

triple-receptor negative breast cancer


Carboplatin + Ipatasertib + Paclitaxel

Carboplatin + Ipatasertib

Atezolizumab + Capecitabine + Ipatasertib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.